@article{76ba933a572f49e2818fa5b56fe9869b,
title = "Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: A complex new scenario",
author = "Giacobbe, {Daniele Roberto} and Lorenzo Ball and Laura Magnasco and Chiara Dentone and Denise Battaglini and Chiara Robba and Paolo Pelosi and Matteo Bassetti",
note = "Funding Information: Outside the submitted work, DRG reports honoraria from Stepstone Pharma GmbH and unconditional grants from MSD Italia, Correvio Italia, and Pfizer Inc. Outside the submitted work, MB has received funding for scientific advisory boards, travel, and speaker honoraria from Angelini, Astellas, AstraZeneca, Basilea, Bayer, BioMe{\'r}ieux, Cidara, Correvio, Cubist, Menarini, Molteni, MSD, Nabriva, Paratek, Pfizer, Roche, Shionogi, Tetraphase, Thermo Fisher, and The Medicine Company. All the other authors have no conflicts of interest to disclose.",
year = "2021",
month = sep,
day = "30",
doi = "10.52586/4954",
language = "English",
volume = "26",
pages = "405--408",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "9",
}